The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Dr Jonathan David Moore
Dr Jonathan David Moore
British born in April 1967Resident in United Kingdom
Registered addresses and corresponding companiesMoore, Jonathan David, Dr
British born in April 1967Resident in United Kingdom
Registered addresses and corresponding companiesMoore, Jonathan David, Dr
British biotechnology executive born in April 1967Resident in United Kingdom
Registered addresses and corresponding companiesMoore, Jonathan David, Dr
British company director born in April 1967Resident in United Kingdom
Registered addresses and corresponding companiesMoore, Jonathan David, Dr
British biotechnology executive born in April 1967Resident in England
Registered addresses and corresponding companies
IIF 9
Citypoint, 3rd Floor, 65 Haymarket Terrace, Edinburgh, EH12 5HD, United Kingdom
- 1CENTAURI ONCOLOGY LIMITED - 2016-03-03 10 Lower Thames Street, LondonDissolved Corporate (9 parents)Equity (Company account)-2,396,811 GBP2021-12-31Officer
2020-11-01 ~ dissolvedIIF 8 - Director → ME - 2 Abbey House, 51 High Street, Saffron Walden, Essex, United KingdomActive Corporate (1 parent)Equity (Company account)47,377 GBP2023-10-31Officer 2018-10-16 ~ nowIIF 4 - Director → MEPerson with significant control 2018-11-16 ~ nowIIF 2 - Ownership of shares – 75% or more → OE
- 3
OUTFOX BIO LIMITED
- nowNANOVATION THERAPEUTICS UK LTD - 2024-11-20 Rutherford Appleton Laboratory, Harwell Oxford, Didcot, EnglandActive Corporate (4 parents)Net Assets/Liabilities (Company account)472,075 GBP2024-12-31Officer 2025-07-03 ~ nowIIF 3 - Director → ME
- 1CENTAURI ONCOLOGY LIMITED - 2016-03-03 10 Lower Thames Street, LondonDissolved Corporate (9 parents)Equity (Company account)-2,396,811 GBP2021-12-31Officer 2016-03-01 ~ 2019-02-26IIF 7 - Director → ME
- 2 Salisbury House, Station Road, Cambridge, Cambridgeshire, United KingdomActive Corporate (6 parents)Profit/Loss (Company account)-1,777,708 GBP2022-05-01 ~ 2023-04-30Officer 2021-04-23 ~ 2023-12-22IIF 5 - Director → MEPerson with significant control 2021-04-23 ~ 2021-11-30IIF 1 - Ownership of shares – 75% or more → OEIIF 1 - Ownership of voting rights - 75% or more → OE
- 3 21g1 Mereside Alderley Park, Macclesfield, Cheshire, United KingdomActive Corporate (6 parents)Net Assets/Liabilities (Company account)5,466,309 GBP2023-08-31Officer 2019-11-20 ~ 2025-08-28IIF 6 - Director → ME
- 4JAGGER THERAPEUTICS LIMITED - 2019-02-12 Citypoint, 3rd Floor, 65 Haymarket Terrace, Edinburgh, United KingdomActive Corporate (7 parents)Officer 2019-03-15 ~ 2022-03-02IIF 9 - Director → ME
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.